Michael de Kok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael de Kok has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Aleksandra M. Mikula
Department of Molecular Cell Biology and Immunology Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam The Netherlands
3 shared publications- Charlotte Maria de Winde
Amsterdam UMC
3 shared publications Henk P. Roest
Department of Surgery Erasmus MC Transplant Institute, University Medical Center Rotterdam Rotterdam The Netherlands
3 shared publications- Luc J. W. van der Laan
Department of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands
3 shared publications - Reina E. Mebius
Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology & Immunology, De Boelelaan 1117, Amsterdam, the Netherlands
3 shared publications Cora H. Chadick
Department of Molecular Cell Biology and Immunology Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam The Netherlands
2 shared publications
Latest Publications
- Open Access
- 16 November 2025
- Published by Wiley in The FEBS Journal
- Vol. 293 (11) , 3187-3210
Ligand‐specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc ‐containing glycan structures
C‐type lectin receptors on dendritic cells shape immune responses to pathogens and tumour cells through the specific recognition of glycans. C‐type lectin domain family 10 member A [CLEC10A; also known as Macrophage Galactose‐type Lectin (MGL)] binds terminal N ‐acetylgalactosamine (GalNAc) residues, which are often highly exposed on tumours. Signalling through this receptor increases Interleukin‐10 (IL‐10) and Tumour Necrosis Factor alpha (TNFα) production by monocyte‐derived dendritic cells (moDCs), which promotes a T helper 2 (Th2) or type 1 regulatory T‐cell (Tr1) response. Recently, several CLEC10A glycan ligands were identified that induce distinct conformational changes in the CLEC10A carbohydrate recognition domain, but their ability to alter moDC function has not been thoroughly explored. Here, we used CLEC10A ligand glycodendrimers to investigate the transcriptional responses induced by the CLEC10A ligands previously modelled and determined how these transcriptional programmes were associated with the cellular moDC responses. The CLEC10A ligand dendrimers varied in their affinity for CLEC10A and their capacity to increase IL‐10 produced by moDCs. Although all glycodendrimers induced differential gene expression, this was strongest for the Forssman antigen dendrimer. The gene ontology (GO) terms associated with genes detected across ligands related to mitogen‐activated protein kinase (MAPK) signalling, chemotaxis, apoptosis, angiogenesis, cytokine production and CD4 + T‐cell differentiation. The CLEC10A ligand dendrimers also altered the chemokine profile secreted by moDCs. Furthermore, these glycodendrimers increased the percentage of C‐C Chemokine Receptor type 7 (CCR7)‐expressing moDCs, which was prevented by inhibiting CLEC10A signalling. Overall, there was limited evidence for glycan‐specific signalling via CLEC10A, but the glycans did alter the magnitude of the CLEC10A‐mediated responses.
- 16 November 2025
- Published by Wiley in The FEBS Journal
- Vol. 293 (11) , 3187-3210
Open AccessLigand‐specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc ‐containing glycan structures
C‐type lectin receptors on dendritic cells shape immune responses to pathogens and tumour cells through the specific recognition of glycans. C‐type lectin domain family 10 member A [CLEC10A; also known as Macrophage Galactose‐type Lectin (MGL)] binds terminal N ‐acetylgalactosamine (GalNAc) residues, which are often highly exposed on tumours. Signalling through this receptor increases Interleukin‐10 (IL‐10) and Tumour Necrosis Factor alpha (TNFα) production by monocyte‐derived dendritic cells (moDCs), which promotes a T helper 2 (Th2) or type 1 regulatory T‐cell (Tr1) response. Recently, several CLEC10A glycan ligands were identified that induce distinct conformational changes in the CLEC10A carbohydrate recognition domain, but their ability to alter moDC function has not been thoroughly explored. Here, we used CLEC10A ligand glycodendrimers to investigate the transcriptional responses induced by the CLEC10A ligands previously modelled and determined how these transcriptional programmes were associated with the cellular moDC responses. The CLEC10A ligand dendrimers varied in their affinity for CLEC10A and their capacity to increase IL‐10 produced by moDCs. Although all glycodendrimers induced differential gene expression, this was strongest for the Forssman antigen dendrimer. The gene ontology (GO) terms associated with genes detected across ligands related to mitogen‐activated protein kinase (MAPK) signalling, chemotaxis, apoptosis, angiogenesis, cytokine production and CD4 + T‐cell differentiation. The CLEC10A ligand dendrimers also altered the chemokine profile secreted by moDCs. Furthermore, these glycodendrimers increased the percentage of C‐C Chemokine Receptor type 7 (CCR7)‐expressing moDCs, which was prevented by inhibiting CLEC10A signalling. Overall, there was limited evidence for glycan‐specific signalling via CLEC10A, but the glycans did alter the magnitude of the CLEC10A‐mediated responses.
- Open Access
- 12 June 2024
- Published by Wiley in Cytometry Part A
- Vol. 105 (8) , 595-606
Unbiased method for spectral analysis of cells with great diversity of autofluorescence spectra
Autofluorescence is an intrinsic feature of cells, caused by the natural emission of light by photo‐excitatory molecular content, which can complicate analysis of flow cytometry data. Different cell types have different autofluorescence spectra and, even within one cell type, heterogeneity of autofluorescence spectra can be present, for example, as a consequence of activation status or metabolic changes. By using full spectrum flow cytometry, the emission spectrum of a fluorochrome is captured by a set of photo detectors across a range of wavelengths, creating an unique signature for that fluorochrome. This signature is then used to identify, or unmix, that fluorochrome's unique spectrum from a multicolor sample containing different fluorescent molecules. Importantly, this means that this technology can also be used to identify intrinsic autofluorescence signal of an unstained sample, which can be used for unmixing purposes and to separate the autofluorescence signal from the fluorophore signals. However, this only works if the sample has a singular, relatively homogeneous and bright autofluorescence spectrum. To analyze samples with heterogeneous autofluorescence spectral profiles, we setup an unbiased workflow to more quickly identify differing autofluorescence spectra present in a sample to include as “autofluorescence signatures” during the unmixing of the full stained samples. First, clusters of cells with similar autofluorescence spectra are identified by unbiased dimensional reduction and clustering of unstained cells. Then, unique autofluorescence clusters are determined and are used to improve the unmixing accuracy of the full stained sample. Independent of the intensity of the autofluorescence and immunophenotyping of cell subsets, this unbiased method allows for the identification of most of the distinct autofluorescence spectra present in a sample, leading to less confounding autofluorescence spillover and spread into extrinsic phenotyping markers. Furthermore, this method is equally useful for spectral analysis of different biological samples, including tissue cell suspensions, peripheral blood mononuclear cells, and in vitro cultures of (primary) cells.
- 12 June 2024
- Published by Wiley in Cytometry Part A
- Vol. 105 (8) , 595-606
Open AccessUnbiased method for spectral analysis of cells with great diversity of autofluorescence spectra
Autofluorescence is an intrinsic feature of cells, caused by the natural emission of light by photo‐excitatory molecular content, which can complicate analysis of flow cytometry data. Different cell types have different autofluorescence spectra and, even within one cell type, heterogeneity of autofluorescence spectra can be present, for example, as a consequence of activation status or metabolic changes. By using full spectrum flow cytometry, the emission spectrum of a fluorochrome is captured by a set of photo detectors across a range of wavelengths, creating an unique signature for that fluorochrome. This signature is then used to identify, or unmix, that fluorochrome's unique spectrum from a multicolor sample containing different fluorescent molecules. Importantly, this means that this technology can also be used to identify intrinsic autofluorescence signal of an unstained sample, which can be used for unmixing purposes and to separate the autofluorescence signal from the fluorophore signals. However, this only works if the sample has a singular, relatively homogeneous and bright autofluorescence spectrum. To analyze samples with heterogeneous autofluorescence spectral profiles, we setup an unbiased workflow to more quickly identify differing autofluorescence spectra present in a sample to include as “autofluorescence signatures” during the unmixing of the full stained samples. First, clusters of cells with similar autofluorescence spectra are identified by unbiased dimensional reduction and clustering of unstained cells. Then, unique autofluorescence clusters are determined and are used to improve the unmixing accuracy of the full stained sample. Independent of the intensity of the autofluorescence and immunophenotyping of cell subsets, this unbiased method allows for the identification of most of the distinct autofluorescence spectra present in a sample, leading to less confounding autofluorescence spillover and spread into extrinsic phenotyping markers. Furthermore, this method is equally useful for spectral analysis of different biological samples, including tissue cell suspensions, peripheral blood mononuclear cells, and in vitro cultures of (primary) cells.
- 19 December 2023
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 21 (3) , 455-471
An Organotypic Human Lymph Node Model Reveals the Importance of Fibroblastic Reticular Cells for Dendritic Cell Function
Background: Human lymph node (HuLN) models have emerged with invaluable potential for immunological research and therapeutic application given their fundamental role in human health and disease. While fibroblastic reticular cells (FRCs) are instrumental to HuLN functioning, their inclusion and recognition of importance for organotypic in vitro lymphoid models remain limited. Methods: Here, we established an in vitro three-dimensional (3D) model in a collagen-fibrin hydrogel with primary FRCs and a dendritic cell (DC) cell line (MUTZ-3 DC). To study and characterise the cellular interactions seen in this 3D FRC-DC organotypic model compared to the native HuLN; flow cytometry, immunohistochemistry, immunofluorescence and cytokine/chemokine analysis were performed. Results: FRCs were pivotal for survival, proliferation and localisation of MUTZ-3 DCs. Additionally, we found that CD1a expression was absent on MUTZ-3 DCs that developed in the presence of FRCs during cytokine-induced MUTZ-3 DC differentiation, which was also seen with primary monocyte-derived DCs (moDCs). This phenotype resembled HuLN-resident DCs, which we detected in primary HuLNs, and these CD1a− MUTZ-3 DCs induced T cell proliferation within a mixed leukocyte reaction (MLR), indicating a functional DC status. FRCs expressed podoplanin (PDPN), CD90 (Thy-1), CD146 (MCAM) and Gremlin-1, thereby resembling the DC supporting stromal cell subset identified in HuLNs. Conclusion: This 3D FRC-DC organotypic model highlights the influence and importance of FRCs for DC functioning in a more realistic HuLN microenvironment. As such, this work provides a starting point for the development of an in vitro HuLN.
- 19 December 2023
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 21 (3) , 455-471
An Organotypic Human Lymph Node Model Reveals the Importance of Fibroblastic Reticular Cells for Dendritic Cell Function
Background: Human lymph node (HuLN) models have emerged with invaluable potential for immunological research and therapeutic application given their fundamental role in human health and disease. While fibroblastic reticular cells (FRCs) are instrumental to HuLN functioning, their inclusion and recognition of importance for organotypic in vitro lymphoid models remain limited. Methods: Here, we established an in vitro three-dimensional (3D) model in a collagen-fibrin hydrogel with primary FRCs and a dendritic cell (DC) cell line (MUTZ-3 DC). To study and characterise the cellular interactions seen in this 3D FRC-DC organotypic model compared to the native HuLN; flow cytometry, immunohistochemistry, immunofluorescence and cytokine/chemokine analysis were performed. Results: FRCs were pivotal for survival, proliferation and localisation of MUTZ-3 DCs. Additionally, we found that CD1a expression was absent on MUTZ-3 DCs that developed in the presence of FRCs during cytokine-induced MUTZ-3 DC differentiation, which was also seen with primary monocyte-derived DCs (moDCs). This phenotype resembled HuLN-resident DCs, which we detected in primary HuLNs, and these CD1a− MUTZ-3 DCs induced T cell proliferation within a mixed leukocyte reaction (MLR), indicating a functional DC status. FRCs expressed podoplanin (PDPN), CD90 (Thy-1), CD146 (MCAM) and Gremlin-1, thereby resembling the DC supporting stromal cell subset identified in HuLNs. Conclusion: This 3D FRC-DC organotypic model highlights the influence and importance of FRCs for DC functioning in a more realistic HuLN microenvironment. As such, this work provides a starting point for the development of an in vitro HuLN.
- Open Access
Unbiased method for spectral analysis of cells with great diversity of autofluorescence spectra
Autofluorescence is an intrinsic feature of cells, caused by the natural emission of light by its cellular content, that can complicate analysis of flow cytometry data. Different cell types have different autofluorescence spectra and even within one cell type heterogeneity of autofluorescence spectra can be present, for example as a consequence of activation status or metabolic changes. By using full spectrum flow cytometry, the emission spectrum of a fluorochrome is captured by a set of detectors across a range of wavelengths, creating an unique spectrum for this fluorochrome, that is used to unmix the signal of a full stained sample into the signals of the different fluorochromes. Importantly, this technology can also be used to identify the aut-ofluorescence signal of an unstained sample, which can be used for unmixing purposes and to separate the autofluorescence signal from the fluorophore signals. However, this only works if the sample has one homogeneous autofluorescence spectrum. To analyze samples with a heterogeneous autofluorescence spectral profile, we here setup an unbiased workflow to detect all different autofluorescence spectra present in a sample to take them along as ‘autofluorescence signatures’ during the unmixing of the full stained samples. First, clusters of cells with similar autofluorescence spectra are identified by unbiased dimensional reduction and clustering. Then, unique autofluorescence clusters are determined and are used to improve the unmixing accuracy of the full stained sample. This unbiased method allows for the identification of all autofluorescence spectra present in a sample, independent of cell types and intensity of the autofluorescence spectra. Furthermore, this method is equally useful for spectral analysis of different biological samples, including tissue cell suspensions, peripheral blood mononuclear cells and in vitro cultures of (primary) cells.
Open AccessUnbiased method for spectral analysis of cells with great diversity of autofluorescence spectra
Autofluorescence is an intrinsic feature of cells, caused by the natural emission of light by its cellular content, that can complicate analysis of flow cytometry data. Different cell types have different autofluorescence spectra and even within one cell type heterogeneity of autofluorescence spectra can be present, for example as a consequence of activation status or metabolic changes. By using full spectrum flow cytometry, the emission spectrum of a fluorochrome is captured by a set of detectors across a range of wavelengths, creating an unique spectrum for this fluorochrome, that is used to unmix the signal of a full stained sample into the signals of the different fluorochromes. Importantly, this technology can also be used to identify the aut-ofluorescence signal of an unstained sample, which can be used for unmixing purposes and to separate the autofluorescence signal from the fluorophore signals. However, this only works if the sample has one homogeneous autofluorescence spectrum. To analyze samples with a heterogeneous autofluorescence spectral profile, we here setup an unbiased workflow to detect all different autofluorescence spectra present in a sample to take them along as ‘autofluorescence signatures’ during the unmixing of the full stained samples. First, clusters of cells with similar autofluorescence spectra are identified by unbiased dimensional reduction and clustering. Then, unique autofluorescence clusters are determined and are used to improve the unmixing accuracy of the full stained sample. This unbiased method allows for the identification of all autofluorescence spectra present in a sample, independent of cell types and intensity of the autofluorescence spectra. Furthermore, this method is equally useful for spectral analysis of different biological samples, including tissue cell suspensions, peripheral blood mononuclear cells and in vitro cultures of (primary) cells.
- Open Access
FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State
Cancer stem cells (CSCs) are located in dedicated niches, where they remain inert to chemotherapeutic drugs and drive metastasis. Although plasticity in the CSC pool is well appreciated, the molecular mechanisms implicated in the regulation of cancer stemness are still elusive. Here, we define a fucosylation-dependent reprogramming of colon cancer cells towards a stem cell-like phenotype and function. De novo transcriptional activation of Fut9 in the murine colon adenocarcinoma cell line, MC38, followed by RNA seq-based regulon analysis, revealed major gene regulatory networks related to stemness. Lewisx, Sox2, ALDH and CD44 expression, tumorsphere formation, resistance to 5-FU treatment and in vivo tumor growth were increased in FUT9-expressing MC38 cells compared to the control cells. Likewise, human CRC cell lines highly expressing FUT9 displayed phenotypic features of CSCs, which were significantly impaired upon FUT9 knock-out. Finally, in primary CRC FUT9+ tumor cells pathways related to cancer stemness were enriched, providing a clinically meaningful annotation of the complicity of FUT9 in stemness regulation and may open new avenues for therapeutic intervention.
Open AccessFUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State
Cancer stem cells (CSCs) are located in dedicated niches, where they remain inert to chemotherapeutic drugs and drive metastasis. Although plasticity in the CSC pool is well appreciated, the molecular mechanisms implicated in the regulation of cancer stemness are still elusive. Here, we define a fucosylation-dependent reprogramming of colon cancer cells towards a stem cell-like phenotype and function. De novo transcriptional activation of Fut9 in the murine colon adenocarcinoma cell line, MC38, followed by RNA seq-based regulon analysis, revealed major gene regulatory networks related to stemness. Lewisx, Sox2, ALDH and CD44 expression, tumorsphere formation, resistance to 5-FU treatment and in vivo tumor growth were increased in FUT9-expressing MC38 cells compared to the control cells. Likewise, human CRC cell lines highly expressing FUT9 displayed phenotypic features of CSCs, which were significantly impaired upon FUT9 knock-out. Finally, in primary CRC FUT9+ tumor cells pathways related to cancer stemness were enriched, providing a clinically meaningful annotation of the complicity of FUT9 in stemness regulation and may open new avenues for therapeutic intervention.